Medicine

STAT+: PTC’s Duchenne muscular dystrophy drug achieves study goal, potentially confirming European approval

This post originally appeared on StatNews.

In-depth analysis of biotech, pharma, and the life sciences

  • Award-winning journalism

    from some of the nation’s most trusted and well-connected reporters in the industry

  • Weekly live video chats

    with STAT+ reporters and leading industry experts in our STAT+ Conversations series

  • Exclusive industry events

    hosted by STAT+, plus early-bird access and discounts to industry events around the country

  • Daily STAT+ newsletters

    get delivered to your inbox to brief you on the most important industry news of the day

  • Premium data tools

    like our CRISPR Trackr and Drug Pricing Policy Tracker

This post originally appeared on StatNews.